David Kantaros Bio

David Kantaros serves as Co-Chair for Artificial Intelligence within our Innovative Technology sector and is a member of the Private Equity & Venture Capital and Transactional & Securities Practices. He represents venture capital and private equity funds as well as publicly and privately held corporations in the emerging technology and life science industries. David’s experience includes: representing private equity funds, family offices, and public and private companies in mergers and acquisitions, joint-ventures, public offerings, and control investments; advising venture capital firms, strategic investors, and high net worth individuals and investment groups in private placement activities, including preferred stock and secured and convertible debt financing in technology and life science companies; counseling high-tech, as well as biotechnology, pharmaceutical and medical device companies as to corporate structure, technology protection and transactional matters; advising investors, corporate boards and public and private companies on complex domestic and cross-border transactions including corporate migrations, re-incorporations and joint venture arrangements; and structuring and negotiating technology license agreements, including master license agreements, OEM agreements, Beta test agreements, shrinkwrap agreements and strategic relationships involving the sharing of technology.